These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 6361700)
21. [Role of certain mechanisms in the pathogenesis of emphysema and a number of other lung diseases]. Putov NV; Pokhodzeĭ IV; Kolodkina LA Ter Arkh; 1985; 57(3):144-8. PubMed ID: 3890255 [No Abstract] [Full Text] [Related]
22. [Oxidants and antioxidants: another look at the pathogenesis of pulmonary emphysema]. Słodkowska J Postepy Hig Med Dosw; 1991; 45(3-4):225-32. PubMed ID: 1658761 [TBL] [Abstract][Full Text] [Related]
23. The pathogenesis of pulmonary emphysema. Lancet; 1980 Apr; 1(8171):743-5. PubMed ID: 6103161 [No Abstract] [Full Text] [Related]
24. Pulmonary emphysema: current concepts of pathogenesis. Weissler JC Am J Med Sci; 1987 Feb; 293(2):125-38. PubMed ID: 3494401 [TBL] [Abstract][Full Text] [Related]
25. [Proteolytic enzymes and their inhibitors in the development of destructive processes in lung diseases]. Kubyshkin AV Sov Med; 1984; (9):42-6. PubMed ID: 6209806 [No Abstract] [Full Text] [Related]
26. Opportunities for the development of specific therapeutic agents to treat emphysema. Cohen AB Am Rev Respir Dis; 1979 Oct; 120(4):723-7. PubMed ID: 389114 [No Abstract] [Full Text] [Related]
27. Design of a clinical trial to test a treatment of the underlying cause of emphysema. Anthonisen N; Connett J; Friedman B; Glass M; Kilday DP; Mingo TS; Rudolphus A; Williams GW Ann N Y Acad Sci; 1991 Dec; 624 Suppl():31-4. PubMed ID: 1686163 [No Abstract] [Full Text] [Related]
28. [Pathogenesis of bullous pulmonary emphysema (a review of the literature)]. Vishnevskiĭ AA; Volkov GM; Nikoladze GD Vrach Delo; 1988 Jul; (7):10-3. PubMed ID: 3055680 [No Abstract] [Full Text] [Related]
29. Neutrophil recruitment into the lungs is associated with increased lung elastase burden, decreased lung elastin, and emphysema in alpha 1 proteinase inhibitor-deficient mice. Cavarra E; Martorana PA; Gambelli F; de Santi M; van Even P; Lungarella G Lab Invest; 1996 Aug; 75(2):273-80. PubMed ID: 8765327 [TBL] [Abstract][Full Text] [Related]
30. [The role of free radical oxidation in the development of bronchopulmonary diseases]. Kubyshkin AV Sov Med; 1989; (6):26-30. PubMed ID: 2678516 [No Abstract] [Full Text] [Related]
31. The effect of the specific elastase inhibitor, alanyl alanyl prolyl alanine chloromethylketone, on elastase-induced emphysema. Kleinerman J; Ranga V; Rynbrandt D; Sorensen J; Powers JC Am Rev Respir Dis; 1980 Feb; 121(2):381-7. PubMed ID: 6899738 [TBL] [Abstract][Full Text] [Related]
32. Alpha 1-antitrypsin, emphysema and smoking. Carrell RW N Z Med J; 1984 May; 97(756):327-8. PubMed ID: 6610142 [No Abstract] [Full Text] [Related]
33. [Incidence of emphysema predisposing factors (alpha 1-antitrypsin deficiency and increased activity of elastase-like esterase in granulocytes) in patients with allergic-infectious asthma]. Rozniecki J; Szmidt M; Ruta U; Bednarowicz A Pneumonol Pol; 1981; 49(10):703-8. PubMed ID: 6977131 [No Abstract] [Full Text] [Related]
34. [Trends in studies on the pathogenesis of pulmonary emphysema]. Słodkowska J Pneumonol Pol; 1982 Oct; 50(10):541-6. PubMed ID: 6189102 [No Abstract] [Full Text] [Related]
35. [Congenital alpha 1-antitrypsin deficiency as an aggravating factor in alveolar injury from cigarette smoke]. Massi G; Cotumaccio R; Auconi P Minerva Med; 1982 Sep; 73(36):2383-5. PubMed ID: 6981079 [No Abstract] [Full Text] [Related]
36. Functional assay of alpha 1-antitrypsin in obstructive lung disease. Billingsley GD; Cox DW Am Rev Respir Dis; 1980 Jan; 121(1):161-4. PubMed ID: 6965439 [TBL] [Abstract][Full Text] [Related]
37. Proteases and lung injury. A state-of-the-art minireview. Janoff A Chest; 1983 May; 83(5 Suppl):54S-58S. PubMed ID: 6340986 [No Abstract] [Full Text] [Related]